Why Has Oxford Biomedica Share Price Fallen?
Oxford BioMedica shares fall after it seeks £30 million for vaccine trial. Shares in Oxford BioMedica, an Oxford University spin-out, fell 8.3 percent on news that the company was seeking up to £30 million to fund the Phase III trial of its a TroVax cancer immunotherapy product. Why are Oxford Biomedica shares going down? Oxford …